Related Experiment Video
Updated: Aug 7, 2026

10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Langerhans cell histiocytosis research. Past, present, and future
Hematology/Oncology Clinics of North America
|April 30, 1998
Summary
This review covers the investigative history behind unifying Hand-Schüller-Christian disease and others under Langerhans cell histiocytosis. Evolving data on the reticuloendothelial system shaped this classification.
Area of Science:
- Histiocytosis Research
- Cellular Pathology
- Medical Terminology Evolution
Background:
- Previously, diverse clinicopathologic conditions like Hand-Schüller-Christian disease were recognized.
- These conditions were often grouped under the umbrella term 'histiocytosis X'.
- The 'reticuloendothelial system' concept influenced early classifications.
Purpose of the Study:
- To review the investigative events leading to the current terminology.
- To explain the shift from older designations to Langerhans cell histiocytosis.
- To highlight the impact of new data on disease classification.
Main Methods:
- Literature review of historical investigative events.
- Analysis of evolving conceptual approaches in histiocytosis.
- Examination of ultrastructural and immunocytochemical data acquisition.
Main Results:
- The term Langerhans cell histiocytosis is now widely accepted.
- This unified term encompasses previously distinct conditions.
- New data significantly altered understanding and classification.
Conclusions:
- The evolution of terminology reflects scientific progress.
- Ultrastructural and immunocytochemical findings were crucial.
- Langerhans cell histiocytosis provides a more accurate classification.
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

